Company intelligence / Profile preview

Viafet

Ownership: Private
Development stage: Commercial

Overview

Viafet operates a network of advanced clinical laboratories specializing in comprehensive genetic testing. Their offerings include whole exome sequencing, carrier screening, preimplantation and prenatal diagnostics, and targeted mutation analysis. The company has contributed to over 240 scientific publications and discovered multiple previously unclassified diseases. They serve clinicians and patients across the Middle East and Australia with a mission to improve access to high-quality genetics-driven healthcare

Therapeutic areas: Rare DiseasesWomen's Health
Industry: Molecular Diagnostics

Partnerships

Collaborates with various organizations globally to expand access to its services

Beyond the preview

Go deeper on Viafet.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Viafet.

Explore the full profile